C-454/00

VIS Farmacetici v. Duphar

The following question of interpretation is referred to the Court of Justice of the EC for a preliminary ruling:

Must Article 4 of Regulation No 1768/92 be interpreted as meaning that the scope of protection of the supplementary certificate extends only to manufacture of the raw material from which is prepared the product which constitutes the medicinal product covered by the marketing authorisation?